AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

Clinical trial NCT01741194 · COMPLETED

Trial details

NCT number: NCT01741194
Sponsor: Cerecin
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2013-03-01
Primary completion: 2016-10-24
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.